Working… Menu

Study to Assess the Safety and Tolerability of a Single Administration of FOV2302 (Ecallantide) in Patients With Macular Edema Associated With Central Retinal Vein Occlusion (FOV2302)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00969293
Recruitment Status : Terminated
First Posted : September 1, 2009
Last Update Posted : January 10, 2012
Information provided by (Responsible Party):
Fovea Pharmaceuticals SA

No Study Results Posted on for this Study
Recruitment Status : Terminated
Actual Primary Completion Date : July 2011
Estimated Study Completion Date : March 2012